Isolagen News
Most Popular Isolagen Story
ALSO NOTED: Tacere gains Pfizer deal; InterMune reports positive hep C results; ArQule CEO resigns; and much more...
> Tacere Therapeutics has inked a development deal with Pfizer for its preclinical hepatitis C drug. The deal is worth up to $145 million in potential milestones and Pfizer is paying an Read more...
Latest Headlines
- March 30, 2009
- March 19, 2008
- November 28, 2007
- July 11, 2007
- November 7, 2006
- August 30, 2006
- August 17, 2006
- June 13, 2006
- October 4, 2005
- July 31, 2005
- July 12, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
